Zhong‐Xia Wang

1.5k total citations
51 papers, 1.2k citations indexed

About

Zhong‐Xia Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhong‐Xia Wang has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Zhong‐Xia Wang's work include Organometallic Complex Synthesis and Catalysis (7 papers), Liver physiology and pathology (6 papers) and MicroRNA in disease regulation (5 papers). Zhong‐Xia Wang is often cited by papers focused on Organometallic Complex Synthesis and Catalysis (7 papers), Liver physiology and pathology (6 papers) and MicroRNA in disease regulation (5 papers). Zhong‐Xia Wang collaborates with scholars based in China, United Kingdom and United States. Zhong‐Xia Wang's co-authors include Chunping Jiang, Junhua Wu, Yin Cao, Yitao Ding, Guang Zhang, Weibo Chen, Dongjun Luo, Anlai Ji, Junyi Wu and Renxiang Tan and has published in prestigious journals such as Advanced Materials, PLoS ONE and Advanced Functional Materials.

In The Last Decade

Zhong‐Xia Wang

49 papers receiving 1.2k citations

Peers

Zhong‐Xia Wang
Zhong‐Xia Wang
Citations per year, relative to Zhong‐Xia Wang Zhong‐Xia Wang (= 1×) peers Monica Notarbartolo

Countries citing papers authored by Zhong‐Xia Wang

Since Specialization
Citations

This map shows the geographic impact of Zhong‐Xia Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhong‐Xia Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhong‐Xia Wang more than expected).

Fields of papers citing papers by Zhong‐Xia Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhong‐Xia Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhong‐Xia Wang. The network helps show where Zhong‐Xia Wang may publish in the future.

Co-authorship network of co-authors of Zhong‐Xia Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhong‐Xia Wang. A scholar is included among the top collaborators of Zhong‐Xia Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhong‐Xia Wang. Zhong‐Xia Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhan, Xiaoyan, Zhao Jia, Wei Shi, et al.. (2024). Schisandrin C enhances type I IFN response activation to reduce tumor growth and sensitize chemotherapy through antitumor immunity. Frontiers in Pharmacology. 15. 1369563–1369563. 7 indexed citations
2.
Li, Shuangqing, Ying Wei, Zheng Xing, et al.. (2024). Acid-mediated strategies designed for stretchable and durable polyacrylamide/sodium alginate dual-network hydrogels toward flexible capacitors and wearable sensors. International Journal of Biological Macromolecules. 276(Pt 2). 134065–134065. 4 indexed citations
3.
Wu, Junyi, Xiangjie Xu, Shasha Wu, et al.. (2023). UBE2S promotes malignant properties via VHL/HIF‐1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma. Cancer Medicine. 12(17). 18078–18097. 7 indexed citations
4.
Wang, Zhanhong, Danli Wang, Wen Liu, & Zhong‐Xia Wang. (2023). Traditional Chinese medicine diagnosis and treatment based on systematics. PubMed. 2(4). 181–187. 5 indexed citations
5.
Sun, Yang, Sheng Yin, Zhong‐Xia Wang, et al.. (2023). Long-term functional maintenance of primary hepatocytes in vitro using macroporous hydrogels engineered through liquid-liquid phase separation. Nano Research. 17(3). 1725–1736. 11 indexed citations
6.
Li, Hui, Xiaoyan Zhan, Wei Luo, et al.. (2023). Glabridin improves autoimmune disease in Trex1-deficient mice by reducing type I interferon production. Molecular Medicine. 29(1). 167–167. 9 indexed citations
7.
Jia, Zhao, Guang Xu, Wei Shi, et al.. (2023). Schisandrin C enhances cGAS-STING pathway activation and inhibits HBV replication. Journal of Ethnopharmacology. 311. 116427–116427. 36 indexed citations
8.
Qiu, Jiannan, Shasha Wu, Peng Wang, et al.. (2022). miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression. Hepatology International. 17(2). 463–475. 9 indexed citations
9.
Ma, Xiao, Ruilin Wang, Zhong‐Xia Wang, et al.. (2022). Metabolomics Profiles Associated with the Treatment of Zuojin Pill on Patients with Chronic Nonatrophic Gastritis. Frontiers in Pharmacology. 13. 898680–898680. 10 indexed citations
11.
Chen, Weibo, Junyi Wu, Weiwei Shi, et al.. (2021). PRRX1 deficiency induces mesenchymal‐epithelial transition through PITX2/miR‐200–dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma. Cancer Science. 112(6). 2158–2172. 10 indexed citations
12.
Zhang, Guang, Zhong‐Xia Wang, Weibo Chen, et al.. (2019). Dual effects of gossypol on human hepatocellular carcinoma via endoplasmic reticulum stress and autophagy. The International Journal of Biochemistry & Cell Biology. 113. 48–57. 7 indexed citations
13.
Wu, Junyi, Anlai Ji, Zhong‐Xia Wang, et al.. (2018). Exosome-Mimetic Nanovesicles from Hepatocytes promote hepatocyte proliferation in vitro and liver regeneration in vivo. Scientific Reports. 8(1). 2471–2471. 86 indexed citations
14.
Liu, Yue, et al.. (2016). Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy. Hepatobiliary & pancreatic diseases international. 15(3). 266–274. 39 indexed citations
15.
Wang, Zhong‐Xia, Weibo Chen, Guang Zhang, et al.. (2014). Baicalein Induces Apoptosis and Autophagy via Endoplasmic Reticulum Stress in Hepatocellular Carcinoma Cells. BioMed Research International. 2014. 1–13. 76 indexed citations
16.
Luo, Dongjun, et al.. (2014). The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma. BioMed Research International. 2014. 1–11. 127 indexed citations
17.
Chen, Weibo, Zhong‐Xia Wang, Chunping Jiang, & Yitao Ding. (2013). PP2A-Mediated Anticancer Therapy. Gastroenterology Research and Practice. 2013. 1–10. 46 indexed citations
18.
Wang, Zhong‐Xia, Yin Cao, Chunping Jiang, et al.. (2012). Lack of Association of Two Common Polymorphisms rs2910164 and rs11614913 with Susceptibility to Hepatocellular Carcinoma: A Meta-Analysis. PLoS ONE. 7(6). e40039–e40039. 44 indexed citations
19.
Chen, Xiaohong, Zhong‐Xia Wang, Ziying Yang, et al.. (2011). Houttuynia cordata blocks HSV infection through inhibition of NF-κB activation. Antiviral Research. 92(2). 341–345. 89 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026